APA (7th ed.) Citation

Weixiang Chen, Yue Zhang, Zuoxiang Wang, Mingyue Tan, Jia Lin, Xiaodong Qian, . . . Tingbo Jiang. (2023). Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Weixiang Chen, Yue Zhang, Zuoxiang Wang, Mingyue Tan, Jia Lin, Xiaodong Qian, Hongxia Li, and Tingbo Jiang. Dapagliflozin Alleviates Myocardial Ischemia/reperfusion Injury by Reducing Ferroptosis via MAPK Signaling Inhibition. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Weixiang Chen, et al. Dapagliflozin Alleviates Myocardial Ischemia/reperfusion Injury by Reducing Ferroptosis via MAPK Signaling Inhibition. Frontiers Media S.A., 2023.